-Semma’s unique investigational approach combines robust production process of pancreatic islet cells with proprietary delivery system to restore insulin secretion in type 1 diabetes patients- BOSTON ...
Semma Therapeutics highlighted the similarity of its stem cell-derived human islets (SC-islets) originating from human pluripotent stem cells with natural pancreas derived islets during a presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback